CENTRAL NERVOUS SYSTEM NEOPLASM
Clinical trials for CENTRAL NERVOUS SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a drug called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to standard therapy. The drug works by blocking enzymes that help tumors grow and form blood vesse…
Matched conditions: CENTRAL NERVOUS SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New drug shows promise for rare childhood cancers
Disease control OngoingThis study tests a drug called larotrectinib in children and young adults with certain cancers that have a specific genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control the cancer. About 33 participants with solid tumors or relapsed leuk…
Matched conditions: CENTRAL NERVOUS SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 04, 2026 16:23 UTC